Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.

Dentali F, Ageno W, Crowther M.

J Thromb Haemost. 2006 Sep;4(9):1853-63. Review.

2.
3.

[Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].

Angelo M, Stockner I, Wiedermann CJ.

Wien Med Wochenschr. 2008;158(21-22):615-20. doi: 10.1007/s10354-008-0610-3. Review. German.

PMID:
19052707
4.

Treatment of warfarin-associated coagulopathy with vitamin K.

Patriquin C, Crowther M.

Expert Rev Hematol. 2011 Dec;4(6):657-65; quiz 666-7. doi: 10.1586/ehm.11.59. Review.

PMID:
22077529
5.

Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.

Cabral KP, Fraser GL, Duprey J, Gibbons BA, Hayes T, Florman JE, Seder DB.

Clin Neurol Neurosurg. 2013 Jun;115(6):770-4. doi: 10.1016/j.clineuro.2012.07.006. Epub 2012 Jul 24.

PMID:
22835715
6.

Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.

Crowther MA, Douketis JD, Schnurr T, Steidl L, Mera V, Ultori C, Venco A, Ageno W.

Ann Intern Med. 2002 Aug 20;137(4):251-4.

PMID:
12186515
7.

Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.

Dezee KJ, Shimeall WT, Douglas KM, Shumway NM, O'malley PG.

Arch Intern Med. 2006 Feb 27;166(4):391-7.

PMID:
16505257
8.

Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.

Gunther KE, Conway G, Leibach L, Crowther MA.

Thromb Res. 2004;113(3-4):205-9.

PMID:
15140584
9.

Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.

Ageno W, Crowther M, Steidl L, Ultori C, Mera V, Dentali F, Squizzato A, Marchesi C, Venco A.

Thromb Haemost. 2002 Jul;88(1):48-51.

PMID:
12152676
10.

The use of vitamin K in patients on anticoagulant therapy: a practical guide.

Hanslik T, Prinseau J.

Am J Cardiovasc Drugs. 2004;4(1):43-55. Review.

PMID:
14967065
11.
12.

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

Ann Intern Med. 2009 Mar 3;150(5):293-300.

PMID:
19258557
14.

Vitamin K for the treatment of asymptomatic coagulopathy associated with oral anticoagulant therapy.

Crowther MA, Wilson S.

J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):69-72. Review.

PMID:
14760216
15.

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage.

Goodnough LT, Shander A.

Blood. 2011 Jun 9;117(23):6091-9. doi: 10.1182/blood-2010-11-316075. Epub 2011 Mar 16. Review.

16.

Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.

Crowther MA, Donovan D, Harrison L, McGinnis J, Ginsberg J.

Thromb Haemost. 1998 Jun;79(6):1116-8.

PMID:
9657434
17.

Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage.

Siddiq F, Jalil A, McDaniel C, Brock DG, Pineda CC, Bell RD, Lee K.

Neurocrit Care. 2008;8(1):36-41.

PMID:
17898941
18.

The risk of hemorrhage among patients with warfarin-associated coagulopathy.

Garcia DA, Regan S, Crowther M, Hylek EM.

J Am Coll Cardiol. 2006 Feb 21;47(4):804-8. Epub 2006 Jan 26.

19.
20.

Warfarin-induced bleeding complications - clinical presentation and therapeutic options.

Wiedermann CJ, Stockner I.

Thromb Res. 2008;122 Suppl 2:S13-8. doi: 10.1016/S0049-3848(08)70004-5. Review.

PMID:
18549907

Supplemental Content

Support Center